Truist Securities Maintains Hold on Zimmer Biomet Holdings, Lowers Price Target to $147
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Richard Newitter maintains a Hold rating on Zimmer Biomet Holdings (NYSE:ZBH) and lowers the price target from $153 to $147.
May 18, 2023 | 1:27 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Truist Securities maintains a Hold rating on Zimmer Biomet Holdings (NYSE:ZBH) and lowers the price target from $153 to $147.
The news directly mentions Zimmer Biomet Holdings (ZBH) and the lowered price target by Truist Securities. This may cause some investors to reconsider their positions, but the Hold rating suggests that the stock is not expected to have significant short-term price movement. The lowered price target may have a neutral impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100